Loss of non-motor kinesin KIF26A causes congenital brain malformations via dysregulated neuronal migration and axonal growth as well as apoptosis
Xuyu Qian,Ellen M DeGennaro,Maya Talukdar,Shyam K Akula,Abbe Lai,Diane D Shao,Dilenny Gonzalez,Jack H Marciano,Richard S Smith,Norma K Hylton,Edward Yang,J Fernando Bazan,Lee Barrett,Rebecca C Yeh,R Sean Hill,Samantha G Beck,Aoi Otani,Jolly Angad,Tadahiro Mitani,Jennifer E Posey,Davut Pehlivan,Daniel Calame,Hatip Aydin,Osman Yesilbas,Kendall C Parks,Emanuela Argilli,Eleina England,Kiho Im,Ajay Taranath,Hamish S Scott,Christopher P Barnett,Peer Arts,Elliott H Sherr,James R Lupski,Christopher A Walsh
DOI: https://doi.org/10.1016/j.devcel.2022.09.011
2022-10-24
Abstract:Kinesins are canonical molecular motors but can also function as modulators of intracellular signaling. KIF26A, an unconventional kinesin that lacks motor activity, inhibits growth-factor-receptor-bound protein 2 (GRB2)- and focal adhesion kinase (FAK)-dependent signal transduction, but its functions in the brain have not been characterized. We report a patient cohort with biallelic loss-of-function variants in KIF26A, exhibiting a spectrum of congenital brain malformations. In the developing brain, KIF26A is preferentially expressed during early- and mid-gestation in excitatory neurons. Combining mice and human iPSC-derived organoid models, we discovered that loss of KIF26A causes excitatory neuron-specific defects in radial migration, localization, dendritic and axonal growth, and apoptosis, offering a convincing explanation of the disease etiology in patients. Single-cell RNA sequencing in KIF26A knockout organoids revealed transcriptional changes in MAPK, MYC, and E2F pathways. Our findings illustrate the pathogenesis of KIF26A loss-of-function variants and identify the surprising versatility of this non-motor kinesin.